Breakthroughs in Plantar Fibromatosis Clinical Trials

Do You Live with Plantar Fibromatosis?

Understanding Palmoplantar Fibromatosis

Palmoplantar fibromatosis, also known as Ledderhose disease, is a rare connective tissue disorder that affects the soles of the feet. It is characterized by the development of hard, fibrous lumps in the arch of the foot, which can cause discomfort, pain, and difficulty walking. This condition is categorized under muscular diseases due to its impact on mobility and the soft tissues in the foot.

While the exact cause of plantar fibromatosis remains unclear, factors such as genetic predisposition, repetitive trauma, or certain medical conditions may contribute to its development. Treatment for plantar fibromatosis can range from conservative measures, such as orthotics and physical therapy, to more advanced interventions like surgery or experimental therapies offered in clinical trials.

Our team is conducting plantar fibromatosis clinical trials in Oklahoma City to evaluate the efficacy and safety of investigational therapies, offering hope for improved care and outcomes.

Joining the clinical trial is entirely voluntary and comes at no cost.

To find out more about plantar fibromatosis clinical trials in Oklahoma City, simply complete the form above.

Exploring New Frontiers in Ledderhose Disease Clinical Trials

This clinical trial is focused on assessing the efficacy, safety, and tolerability of EN3835 compared to a placebo for the treatment of plantar fibromatosis. As part of this groundbreaking research, participants will have the opportunity to receive cutting-edge care while contributing to the advancement of treatments for this debilitating condition.

The study aims to address the challenges of living with lumps in the arch of the foot and explore how investigational therapies can improve patients’ quality of life. By participating, you join the forefront of clinical research in muscular diseases and play a vital role in shaping the future of treatment for plantar fibromatosis.

All study-related procedures and treatments, including the investigational drug, are offered free of charge, with no insurance required for participation.

The study doctor will support you throughout the clinical trial, addressing any questions you have about the study and treatment before you make your decision to participate.

Plantar Fibromatosis Clinical Trial: What to Expect

Participating in plantar fibromatosis clinical trials provides an opportunity to access advanced care while contributing to research on potential treatments. Here’s what you can expect during the trial:

When you join the study, you will first sign an Informed Consent Form, which explains the study’s purpose, procedures, potential risks, and your responsibilities. A study team member will guide you through the form, answer questions, and help you make an informed decision. After enrolling, the study will assess the safety, efficacy, and tolerability of investigational treatments for plantar fibromatosis, including a study drug.

Participating in plantar fibromatosis clinical trials in Oklahoma City or other locations allows you to access innovative treatments while aiding medical research.

Take a step toward improving your health and contributing to advancements in the treatment for plantar fibromatosis by exploring Ledderhose disease clinical trials today.